A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. When Baby KJ was introduced to the world ...
RFK Jr.'s vaccine questions in Samoa, former Stanford president rebuts fraud allegations, and more health news from Morning ...
Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news ...
Juul has received FDA clearance to sell an updated version of its e-cigarette, which includes an optional age-verification ...
AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a ...
AstraZeneca detailed the surprise failure of a closely watched heart disease clinical trial, laying out how its experimental ...
Sword Health, a digital health company plans to acquire mental health services provider Headspace, according to a regulatory ...
The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first to ...
WASHINGTON — Sen. Bill Cassidy (R-La.) released a report on Thursday criticizing the Food and Drug Administration for not ...
Hear STAT reporters interview the year’s biggest newsmakers on the state of the industry. Y ou’re reading the web edition of ...
Opposition to abortion restrictions should focus on values, not statistics, writes David N. Hackney, author of “Impossible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results